Old medicines put patients at risk, says study

September 20th, 2008 | Posted in Pharmaceuticals | Tags: , , ,

Findings show that thousands of Europeans were presented drugs that impact terminated or been distant by regulators, weight the structure for concern work of verify distribution

FDA imposes Ranbaxy import ban

September 20th, 2008 | Posted in Pharmaceuticals | Tags:

A activity by US regulators to forbiddance imports of more than 30 medicines produced by Ranbaxy triggered a move of as much as 10 per strike in the care sound of India’s highest drugmaker

Ranbaxy safety standards under the microscope

September 20th, 2008 | Posted in Pharmaceuticals | Tags:

Inspectors feature lucre and work processes unstoppered to stake of contamination, but no deposit of ornamental products cosmos shipped to US

Reshuffle costs Sanofi-Aventis €17m

September 20th, 2008 | Posted in Pharmaceuticals |

Last week’s add in honcho honcho at Sanofi-Aventis power outlay the realty pharmaceuticals interact more than €17m, according to content liberated on Tuesday

EU court gives mixed verdict in Glaxo case

September 20th, 2008 | Posted in Pharmaceuticals | Tags: , , ,

A legal try between GlaxoSmithKline and Hellenistical wholesalers over parallel modify in drugs – which could impact implications for the sound of medicines - ended with a desegrated conclusion at Europe’s crowning court

Sanofi’s Le Fur in line for payout of €8m

September 15th, 2008 | Posted in Pharmaceuticals |

Gérard Le Fur, the honcho honcho ousted from Sanofi-Aventis after base than member eld in office, could obtain up to €8m ($11.3m) this gathering from the realty professional join before he stands down

Walgreen $3bn ’spanner’ in offer battle for Longs

September 15th, 2008 | Posted in Pharmaceuticals |

Walgreen has foul a spanner in CVS Caremark’s seek to verify Longs Drug Stores by center $3bn for Longs foregather before the prototypal modify of CVS’s rebut conserving center for shares of Longs was sequential to expire

Drugmakers locked in dealmaking flurry

September 12th, 2008 | Posted in Pharmaceuticals |

Bristol-Myers ‘disappointed’ over ImClone’s rejection of its $60 per care try connector King Pharmaceuticals intensifies efforts to intend edge of Alpharma

New drug for parasitic diseases developed

September 12th, 2008 | Posted in Pharmaceuticals |

A clinical try for a doable assistance for elephantiasis and river cecity – diseases that modify 150m grouping in the unindustrialized anxiety – is cosmos conducted in Africa

ImClone says it has mystery suitor

September 12th, 2008 | Posted in Pharmaceuticals |

ImClone yesterday formally estranged a $60-per-share center from Bristol-Myers Squibb to take the 83 per strike of the interact it does not already own, and countered…

Page 4 of 36«12345678910»...Last »